This presentation will serve as an educational opportunity to review the current and emerging drug trends being seen in the United States including discussion on shifting drug markets of opioids and stimulants and the introduction of novel substances such as Xylazine, Tianeptine, and Medetomidine as adulterants. Evidence will be presented in an easy to digest format for all audience members, but a focus on medical intervention will be discussed. Learner Objectives Describe Common Drugs in the Country. Describe New and Emerging Substances being introduced into the illict market. Review Common Myths and Misconceptions about Substance Use and Illicit Drugs. Presenters Daniel Wicklund, DNPc, RN, CARN; Corewell Health, Grand Rapids, Michigan Dan is a nursing doctoral candidate and board certified addictions nurse. Dan’s dissertation work has centralized around the utilization of RN’s at the top of their licensure to expand health access points in underserved communities. Dan also serves as a nurse educator and primary policy writer for a large health system bringing the influence of harm reduction principles into clinical practice. Colleen Lane, MD, FASAM, AAHIVS; Corewell Health; Grand Rapids, Michigan Colleen is a triple board certified physician currently serving as Medical Director of Addiction Medicine at Corwell Health. Dr. Lane brings her background of HIV medicine and Primary Care to the world of addiction to ensure that harm reduction and patient autonomy are central to substance use treatment. Nursing CE This webinar is approved for Nursing CE with the California Board of Nursing.